IGI Snapshot
IGI is betting big on small things. The company manufactures creams, liquids, and other topical products for drug and cosmetics companies using its microencapsulation technology. It originally licensed the technology, dubbed Novasome, from drug firm Novovax. The Novasome process entraps and protects the active ingredients of various skin care products, moisturizers, shampoos, and fragrances, allowing for greater stability during storage and a more controlled release when used. The company is examining further applications of the Novasome technology in food, personal care products, and pharmaceuticals.